These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 22057914)

  • 1. MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis.
    Cheng Y; Zhang Y; Zhang L; Ren X; Huber-Keener KJ; Liu X; Zhou L; Liao J; Keihack H; Yan L; Rubin E; Yang JM
    Mol Cancer Ther; 2012 Jan; 11(1):154-64. PubMed ID: 22057914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy contributes to gefitinib-induced glioma cell growth inhibition.
    Chang CY; Kuan YH; Ou YC; Li JR; Wu CC; Pan PH; Chen WY; Huang HY; Chen CJ
    Exp Cell Res; 2014 Sep; 327(1):102-12. PubMed ID: 24876095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells.
    Bokobza SM; Jiang Y; Weber AM; Devery AM; Ryan AJ
    Oncotarget; 2014 Jul; 5(13):4765-78. PubMed ID: 24946858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of RAD001 and MK-2206 exerts synergistic cytotoxic effects against PTEN mutant gastric cancer cells: involvement of MAPK-dependent autophagic, but not apoptotic cell death pathway.
    Ji D; Zhang Z; Cheng L; Chang J; Wang S; Zheng B; Zheng R; Sun Z; Wang C; Zhang Z; Liu R; Zhang X; Liu X; Wang X; Li J
    PLoS One; 2014; 9(1):e85116. PubMed ID: 24416349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo.
    Hirai H; Sootome H; Nakatsuru Y; Miyama K; Taguchi S; Tsujioka K; Ueno Y; Hatch H; Majumder PK; Pan BS; Kotani H
    Mol Cancer Ther; 2010 Jul; 9(7):1956-67. PubMed ID: 20571069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206.
    Cheng Y; Ren X; Zhang Y; Patel R; Sharma A; Wu H; Robertson GP; Yan L; Rubin E; Yang JM
    Cancer Res; 2011 Apr; 71(7):2654-63. PubMed ID: 21307130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancer.
    Dragowska WH; Weppler SA; Wang JC; Wong LY; Kapanen AI; Rawji JS; Warburton C; Qadir MA; Donohue E; Roberge M; Gorski SM; Gelmon KA; Bally MB
    PLoS One; 2013; 8(10):e76503. PubMed ID: 24146879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gefitinib-resistance is related to BIM expression in non-small cell lung cancer cell lines.
    Li H; Zhou S; Li X; Wang D; Wang Y; Zhou C; Schmid-Bindert G
    Cancer Biother Radiopharm; 2013 Mar; 28(2):115-23. PubMed ID: 23270470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-450a-5p strengthens the drug sensitivity of gefitinib in glioma chemotherapy via regulating autophagy by targeting EGFR.
    Liu Y; Yang L; Liao F; Wang W; Wang ZF
    Oncogene; 2020 Sep; 39(39):6190-6202. PubMed ID: 32820249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid sensitizes human glioma cells to gefitinib-induced autophagy.
    Chang CY; Li JR; Wu CC; Ou YC; Chen WY; Kuan YH; Wang WY; Chen CJ
    IUBMB Life; 2015 Nov; 67(11):869-79. PubMed ID: 26488897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy and the functional roles of Atg5 and beclin-1 in the anti-tumor effects of 3beta androstene 17alpha diol neuro-steroid on malignant glioma cells.
    Graf MR; Jia W; Johnson RS; Dent P; Mitchell C; Loria RM
    J Steroid Biochem Mol Biol; 2009 Jul; 115(3-5):137-45. PubMed ID: 19375507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy inhibition induces enhanced proapoptotic effects of ZD6474 in glioblastoma.
    Shen J; Zheng H; Ruan J; Fang W; Li A; Tian G; Niu X; Luo S; Zhao P
    Br J Cancer; 2013 Jul; 109(1):164-71. PubMed ID: 23799852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells.
    Sun Q; Ming L; Thomas SM; Wang Y; Chen ZG; Ferris RL; Grandis JR; Zhang L; Yu J
    Oncogene; 2009 Jun; 28(24):2348-57. PubMed ID: 19421143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells.
    Han W; Pan H; Chen Y; Sun J; Wang Y; Li J; Ge W; Feng L; Lin X; Wang X; Wang X; Jin H
    PLoS One; 2011; 6(6):e18691. PubMed ID: 21655094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
    Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AKT inhibitor MK-2206 is cytotoxic in hepatocarcinoma cells displaying hyperphosphorylated AKT-1 and synergizes with conventional chemotherapy.
    Simioni C; Martelli AM; Cani A; Cetin-Atalay R; McCubrey JA; Capitani S; Neri LM
    Oncotarget; 2013 Sep; 4(9):1496-506. PubMed ID: 24036604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of AMPK-dependent autophagy enhances in vitro antiglioma effect of simvastatin.
    Misirkic M; Janjetovic K; Vucicevic L; Tovilovic G; Ristic B; Vilimanovich U; Harhaji-Trajkovic L; Sumarac-Dumanovic M; Micic D; Bumbasirevic V; Trajkovic V
    Pharmacol Res; 2012 Jan; 65(1):111-9. PubMed ID: 21871960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The polynuclear platinum BBR3610 induces G2/M arrest and autophagy early and apoptosis late in glioma cells.
    Shingu T; Chumbalkar VC; Gwak HS; Fujiwara K; Kondo S; Farrell NP; Bogler O
    Neuro Oncol; 2010 Dec; 12(12):1269-77. PubMed ID: 20713409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics.
    Cragg MS; Kuroda J; Puthalakath H; Huang DC; Strasser A
    PLoS Med; 2007 Oct; 4(10):1681-89; discussion 1690. PubMed ID: 17973573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of gefitinib and DNA methylation inhibitor decitabine exerts synergistic anti-cancer activity in colon cancer cells.
    Lou YF; Zou ZZ; Chen PJ; Huang GB; Li B; Zheng DQ; Yu XR; Luo XY
    PLoS One; 2014; 9(5):e97719. PubMed ID: 24874286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.